Clinical Genomics Technologies Company

Clinical Genomics is a privately held biotechnology company developing innovative products for colorectal cancer diagnosis and monitoring. With a broad intellectual property portfolio including more than 20 issued and pending patents, Clinical Genomics has developed and validated a sensitive and specific blood test for colorectal cancer recurrence monitoring that will be launched in the U.S. in 2016. This 2-gene test, which is based on methylated DNA from two genes, BCAT1 and IKZF1, is currently known by its project name GEMINI.
Technology: diagnostics
Industry: Biotechnology, Genetics, Health Care, Health Diagnostics
Headquarters: Sydney, New South Wales, Australia
Founded Date: 38718
Employees Number: 101-250
Funding Status: Early Stage Venture
Estimated Revenue: $10M to $50M
Last Funding Date: 2018-06-01
Last Funding Type: Series B

Visit Website
contact@clinicalgenomics.com
https://twitter.com/CGSavesLives
Register and Claim Ownership